2014 Conference
17th GERPAC Conference
12th European GERPAC
Simulation and risks assessment for pharmaceutical preparation at hospital pharmacy
12th European GERPAC
Simulation and risks assessment for pharmaceutical preparation at hospital pharmacy
Chemical contamination risks
Evaluation of working practice and chemical contamination - Oncology day care units
Rudolf Schierl and Bettina Kopp
Institute for Occupational, Social and Environmental MedicineUniversity Munich, Germany (rschierl@med.lmu.de)
Exposure of patient’s family members to cytostatic drugs via excreta
Paul Sessink1, Michiko Yuki2, Satoko Sekine2, Kanae Takase2, Takashi Ishida2
1 Exposure Control Sweden ABWeb: www.exposurecontrol.nl Email: info@exposurecontrol.nl
2 Fukushima Medical University Japan
NIOSH Guidance for the Safe Handling of Hazardous Drugs
Thomas H. Connor
Division of Applied Research and TechnologyNational Institute for Occupational Safety and Health
Cincinnati, Ohio, USA
Risk model for exposure to toxic substances at preparation in the pharmacy
Yvonne Bouwman-Boer
Dutch Pharmacists’ AssociationDen Haag, The Netherlands
Oral dose preparation at pharmacies: evaluation of pharmaceutical dust exposure
Kenneth W. Fent, Srinivas Durgam, Douglas Evans, and Charles Mueller
Research Industrial Hygienist, Centers for Disease Control and Prevention, USA
Disinfection - Simulation
Key points for Cleanroom Disinfection
Tim Sandle
Head of Microbiology at Bio Products Laboratory Limited, UK
Simulation in pharmaceutical compounding: generality and interest for operators preparation
Rémy Collomp1, Fabienne Wong2, Julien Duquesne2, Brigitte Bonan3, Bertrand Decaudin4, Pascal Bonnabry5
1 Hospital Pharmacist, CHU Nice, SFPC Vice President2 CHU Nice
3 Hôpital Foch
4 CHRU Lille
5 HU Genève
How simulation can help improve the safety of processes
Pascal Bonnabry
Pharmacy, Geneva University Hospitals (HUG), Section of pharmaceutical sciences, University of Geneva, University of Lausanne,
Geneva, Switzerland
Media fill tests: application for aseptic preparation at hospital pharmacy
Sylvie Crauste-Manciet
MCU-PH - CHU de BordeauxUniversité de Bordeaux. France
Integrity Testing of Syringes
A. M. Beaney1, A. Deer2
1 Regional Quality Assurance SpecialistNorth-East England, UK
2 Stockton Quality Control Laboratory
North Tees Hospital
England, UK
Hot topics
Oral formulations for paediatrics: palatability studies
Catherine Tuleu
Reader in PharmaceuticsUCL school of Pharmacy
London, UK
Quality Assurance and Human Factor
Thomas Pefferkorn
PhD in PharmacyAktehom Belgium Consultant
Economic impact of prescribing error prevention with computerized physician order entry of injectable antineoplastic drugs
C. Fagnoni-Legat
CHU de Besançonbd Fleming 25030 Besançon Cedex, France
Short oral scientific communications
Feedback subscontracting experience in emergency of chemotherapy preparations
Flavie Mouries, Sylvie Ferrari-Fernandez, Sandra Laclau, Georges Dumont, Jean-Yves Jomier
Unité pharmaceutique oncologique, Centre Hospitalier de Pau, 4 Boulevard Hauterive
64000 PAU, France
When the subcontracting of cytotoxic drugs is unfeasible, what to do?
A.Beausir, C.Fournier, B.Frimat
Service Pharmacie, Centre hospitalier de Lens
Can a theoretical training improve calculation performance of production technicians?
Benjamin Mouchet1, Lucie Bouchoud2, Pascal Bonnabry1,2
1 Section of pharmaceutical sciences, University of Geneva, University of Lausanne, Geneva, Switzerland2 Pharmacy, Geneva University Hospitals (HUG), Geneva, Switzerland
Capsules manufacturing securisation with a new training tool
M. Rauturier1, M. Jobart2, C. Madoui2, M.L. Brandely2, V. Chedru-Legros1
1 Pharmacy, CHU Caen, Avenue de la Côte de Nacre, 14033 Caen, France2 Pharmacy, Hôtel Dieu, Paris, France
Implementation of an approach : « Patient actor of his treatment»
P. Hunault, C. Nowak, I. Baudin
Service Pharmacie (France)CH Angoulême
Batch preparation of a speciality to reconstitute: case of cyclophosphamide
Caroline Ménard, Géraldine Michel, Dieynaba Sankhare, Pierre Faure, Hélène Levert, Nathalie Jourdan
Unité de préparation des anticancéreux (UPAC)Pharmacie, Hôpital Saint Louis, 75010 Paris
Development of analytical control for low-volume cytotoxic preparations destinated to pediatric patients
T. Chouquet, K.Morand, G. Benoît
Hôpital Armand Trousseau, Pharmacie, 26 avenue Arnold-Netter 72012 Paris, France
Validation of a dematerialized process coupled to a gravimetric control in process during cytotoxic compounding
M. Kolski, J. Fouque, F. Pichon, A. Hurgon, L. Escalup
Institut Curie service Pharmacie, 26 rue d’Ulm, 75005 Paris, FRANCE
Drug administration optimization : trial of a new safety infusion system
E. Ducret, C. Chauvin, S. Savouroux, P. Thomare
Unité de pharmacie clinique oncologique, Hôpital Hôtel-Dieu, PHU7 CHU de Nantes, France
Impact of the reassurance of the doxorubicin administration by syringe on the occupational exposure
O. Sidikou1, N. Simon1,2, M. Vasseur1, M. Pinturaud1, C. Richeval3, D. Allorge3, G. Sergent4, B. Décaudin1,2, P. Odou1,2
1 Institut de Pharmacie, CHRU, Lille, France2 EA 4481, Laboratoire de Biopharmacie, Pharmacie Galénique et Hospitalière, Faculté de Pharmacie, Lille, France
3 Laboratoire de Toxicologie, CHRU, Lille, France
4 Service d’imagerie digestive diagnostique et interventionnelle, CHRU, Lille, France
Augmented reality for risks management in injectable drugs preparation in hospital pharmacy
Sarah Ben Othman1, Aurélie Foinard2, Périnne Herbommez3, Lurent Storme3, Bertrand Decaudin2, Slim Hammadi1, Pascal Odou2
1 Ecole Centrale de Lille, France2 Institut de Pharmacie ( EA 4481), CHRU de Lille, France
3 Service de néonatalogie, CHRU de Lille, France
The validation of an automated self-cleaning process in a new robot for the preparation of cytotoxic drugs
María José Tamés1, Gerardo Cajaraville Ordoñana1, Laurence Goldberg2
1 Pharmacy Department, Onkologikoa, San Sebastián, Spain2 Pharmaceutical Consultancy, Manchester, United Kingdom
Can the multi-packaging be a vector of chemical contamination in isolator?
M. Pinturaud1, M. Vasseur1, N. Simon1,2, C. Richeval3, D. Allorge3, B. Décaudin1,2, P. Odou1,2
1 Institut de Pharmacie, CHRU, Lille, France2. EA 4481, Laboratoire de Biopharmacie, Pharmacie Galénique et Hospitalière, Faculté de Pharmacie, Lille, France
3 Laboratoire de Toxicologie, CHRU, Lille, France
Use of a risk analysis methodology to evaluate and follow the risk of exposure of healthcare workers to cytotoxic drugs
Laetitia Lê1,2, Yann Orven2, Patrice Prognon1,2, Eric Caudron1,2
1 Université Paris Sud, EA 4041, 5 rue Jean Baptiste Clément, 92290 Chatenay Malabry2 Hôpital Européen Georges Pompidou (AP-HP), Service de Pharmacie, 20 rue Leblanc, 75015 Paris
ETOPOPHOS 170 mg/m2 = ETOPOPHOS 150 mg/m2 ? What’s wrong with that ?
A. Gourlet, H. Martin, J. Scherer, A. Wibaux, V. Moinard, J. Gressier
Pharmacie, Centre Hospitalier de Roubaix, Bd Lacordaire, France
Evaluation of a quality control’s software after 8 months of use
M. Friou, A. Baudoin, A. Jourand, A. Venet, J. Grellet
UPS Hôpital PellegrinCHU de Bordeaux
place Amélie Raba Léon, 33 076 Bordeaux cedex
Hydrogen peroxide indicators for validation of isolator sterilization with peracetic acid
C. Depaquy, C. Dufour, R. Vazquez, M-N Guerrault-Moro, S. Crauste-Manciet
CHI Poissy Saint Germain-en-LayeSaint Germain-en Laye France
Monoclonal Antibody (MAB) analytical control within a Centralized Chemotherapy Preparation Unit (CCPU): a 9 months activity report
M. Leroy, H. Laouar, D. Morel, S. Edet, A. Sarrazin, M. Rigal, A. Jacolot, C. Padoin
Unité de Préparation et de Contrôle des Chimiothérapies anticancéreusesPUI Avicenne
HUPSSD, AP-HP, Bobigny.
Stability study of injectable preparation used in neonatology
ML. Tall1*, E. Diouf1, S. Haÿs2,3, B. Ducarre1, M. Lenfant1, M. Bador1, N. Koog1, D. Salmon1,4, F. Pirot1,4, C. Pivot1
1 Pharmacie, Groupement Hospitalier Edouard Herriot, 5 place d’Arsonval, 69437 Lyon cedex 03, France2 Service de Néonatologie et Réanimation néonatale, Groupement Hospitalier Nord, 103 grande rue de la Croix Rousse 69317 Lyon cedex 04, France
3 Centre de Recherche en Nutrition Humaine, Rhône Alpes, Groupement Hospitalier Sud, 165 chemin du Grand Revoyet, 69495 Pierre-Bénite Cedex, France
4 Laboratoire de Recherche et développement de Pharmacie Galénique Industrielle, Faculté de Pharmacie, EA 4169 "Fonctions Physiologiques et Pathologiques de la Barrière Cutanée", Université Claude Bernard Lyon 1, 8 avenue Rockefeller, 69373 Lyon cedex 08, France
Repackaging of solid oral dosage forms : interest of the evaluation of tablet physical parameters
M. Garcès1, J. Gaudas1, MN. Guerrault-Moro1, R. Vazquez1, C. Charrueau2, S. Crauste-Manciet1,2
1 Pharmacie - Pharmacotechnie, Centre Hospitalier Intercommunal de Poissy Saint-Germain-en-Laye. Saint-Germain-en-Laye2 UTCBS UMR CNRS 8258 U1022 INSERM Faculté de Pharmacie- Université Paris Descartes, Sorbonne Paris Cité
Technological maturity of the non-intrusive Raman spectroscopy, routinely applied to the automated pre-delivery quality control of ganciclovir compounded at the hospital: validation and comparison vs. high performance liquid chromatography reference method
Flavie Ader, Alexandre Amin, Fabrice Vidal, Philippe Bourget*
Service de Pharmacie Clinique, HU Necker-Enfants Malades, 149 rue de Sèvres, 75015 Paris, France. *philippe.bourget@nck-aphp.fr
Comparison of clean surfaces contamination by bioluminescence technology and microbiological technic
S. Lambert1, T. Mboua2, L. Belotti1, A.C. Gairard-Dory2, B. Gourieux2, T. Lavigne1
1 Service d’hygiène, Hôpitaux Universitaires de Strasbourg - France2 Pharmacie-Stérilisation, Hôpitaux Universitaires de Strasbourg - France
Comparison of the bioluminescence technology to the sterility test of the hospital preparations
T. Mboua, S. Lambert, L. Belotti, B. Gourieux, A.C. Gairard-Dory, T. Lavigne
CHU de Strasbourg 67100
Evaluation of a novel formulation of Mitomycin C eye drops
Marina Castano1,2, Lynn Morrison1, Alexander B. Mullen2
1 GG&C NHS, Regional Quality Assurance Service, Stobhill Hospital, Glasgow, UK2 University of Strathclyde, SIPBS, Glasgow, UK
Workshops
Workshop 1: Isolator validation for hospital pharmacy preparation
Modérateurs : F. Sadeghipour1, P. Hild2, D. Meyer3
1 Pharmacien, Chef de service CHUV, Lausanne2 PH Pharmacien, Chef de Service Roanne
3 Expert micro-environnements - DMcompliance
Workshop 2: How to manage a project aiming to secure the patient treatment dispensing by automation
Modérateurs : Dr S. Armand Branger1, Dr F. Jacq2, Dr S. Colomes3
1 PH Pharmacien, Centre de Santé Mentale (CESAME), Angers 2 PH Pharmacien, Chef de Service CHS La Charité sur Loire
3 PH Pharmacien, Chef de Service, CHS Thuir
Workshop 3: Education tool for hospital technicians used in an injectable cytotoxic preparation service
Modérateurs : Dr C. Nowak1, L. Danguy des Déserts2, M. Boschel3, Dr P. Rohrbach4
1 PH Pharmacien, CH Angoulême2 Interne en Pharmacie, CH Angoulême
3 Préparateur en pharmacie, CH Angoulême
4 PH Pharmacien, Verdun
Workshop 4 : Open questions regarding drug preparation in pharmacy departments: A workshop of special interest groups of the German Society of Hospital Pharmacists ADKA e.V. (in German language)
Modérateur : Pr I. Krämer
Director of the Pharmacy, Department at the Medical Center of Johannes Gutenberg-University Hospital,
Mainz, Germany
Workshop 5: How to manage errors in sterile preparation units?
Moderators: A. Beaney1, J. Smith2
1 Regional Quality Assurance Specialist, North-East England, UK2 Pharmaceutical Director, Viridian Pharma, South Wales, UK
